Tonix Pharmaceuticals Announces Acceptance of Two Fibromyalgia-Related Abstracts for Presentation at EULAR
News
Tonix Pharmaceuticals Holding Corp, a clinical-stage firm currently advancing next-generation medicines to address the unmet needs related to post-traumatic stress disorder, fibromyalgia, and episodic tension-type headache, recently announced that two of the company’s abstracts were accepted and ... Read more